| scholarly article | Q13442814 |
| P50 | author | Yvette E Fisher | Q57058701 |
| P2093 | author name string | Carlos Cepeda | |
| Michael S Levine | |||
| Véronique M André | |||
| X William Yang | |||
| Sumedha Singh | |||
| My Huynh | |||
| Nora Bardakjian | |||
| P2860 | cites work | Therapeutic interventions for symptomatic treatment in Huntington's disease | Q24239893 |
| Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter | Q24310836 | ||
| The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease | Q44029787 | ||
| Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease | Q44282485 | ||
| Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. | Q44306949 | ||
| Mice transgenic for exon 1 of Huntington's disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum. | Q44418548 | ||
| Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons | Q44463501 | ||
| Effects of intrastriatal administration of selective dopaminergic ligands on spontaneous stereotypy in mice | Q44740585 | ||
| The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement | Q44850760 | ||
| The quinolinic acid model of Huntington's disease: locomotor abnormalities | Q45021251 | ||
| Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease | Q45289366 | ||
| Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease | Q45291252 | ||
| Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice | Q45293000 | ||
| Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry | Q45293391 | ||
| Neuropathological classification of Huntington's disease | Q45297167 | ||
| Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease | Q45299022 | ||
| Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial | Q45300094 | ||
| Catecholamine exocytosis is diminished in R6/2 Huntington's disease model mice | Q45306447 | ||
| Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load | Q45306738 | ||
| Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol | Q46570512 | ||
| Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice | Q48158205 | ||
| D-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats. | Q51481821 | ||
| Functional anatomy of movement disorders | Q24544908 | ||
| Synaptic organisation of the basal ganglia | Q24544917 | ||
| Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease | Q24657764 | ||
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| Distinct functions of the two isoforms of dopamine D2 receptors | Q28138415 | ||
| A gene expression atlas of the central nervous system based on bacterial artificial chromosomes | Q29617753 | ||
| Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease | Q30490632 | ||
| Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice | Q31403773 | ||
| Differential loss of striatal projection neurons in Huntington disease | Q33637273 | ||
| Replicating Huntington's disease phenotype in experimental animals | Q33749061 | ||
| Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. | Q33857802 | ||
| Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice | Q34098463 | ||
| Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease | Q34168124 | ||
| Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. | Q34359201 | ||
| The neostriatal mosaic: multiple levels of compartmental organization | Q35318347 | ||
| Dichotomous anatomical properties of adult striatal medium spiny neurons | Q35607269 | ||
| Dopaminergic signaling and striatal neurodegeneration in Huntington's disease | Q35839434 | ||
| Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease | Q36016647 | ||
| Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses | Q36054269 | ||
| Disinhibition as a basic process in the expression of striatal functions | Q36586037 | ||
| Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated | Q36599964 | ||
| The corticostriatal pathway in Huntington's disease | Q36684263 | ||
| A systematic review of the treatment studies in Huntington's disease since 1990. | Q36719669 | ||
| Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice | Q37072467 | ||
| Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice. | Q37121377 | ||
| Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice | Q37157882 | ||
| Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease | Q37311202 | ||
| Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum | Q37723743 | ||
| Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients | Q38288534 | ||
| Short-term synaptic plasticity | Q38613257 | ||
| Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness | Q40217476 | ||
| The basal ganglia and adaptive motor control | Q40706589 | ||
| From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters | Q40713073 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice | Q42513638 | ||
| Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids. | Q43187066 | ||
| Time-dependent actions of D2 family agonist quinpirole on spontaneous behavior in the rat: dissociation between sniffing and locomotion | Q43605001 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Huntington's disease | Q190564 |
| electrophysiology | Q1154774 | ||
| P304 | page(s) | 1170-1182 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Differential electrophysiological changes in striatal output neurons in Huntington's disease | |
| P478 | volume | 31 |
| Q47630786 | A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers. |
| Q37345118 | A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease |
| Q34552247 | Age-related behavioral phenotype of an astrocytic monoamine oxidase-B transgenic mouse model of Parkinson's disease |
| Q36300365 | Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice. |
| Q35055022 | Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease |
| Q35560350 | Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease |
| Q55438236 | Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease. |
| Q41720511 | An Automated Home-Cage System to Assess Learning and Performance of a Skilled Motor Task in a Mouse Model of Huntington's Disease |
| Q35039492 | An Improved BAC Transgenic Fluorescent Reporter Line for Sensitive and Specific Identification of Striatonigral Medium Spiny Neurons |
| Q42190041 | Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease |
| Q37507773 | Cholinergic Interneurons Amplify Corticostriatal Synaptic Responses in the Q175 Model of Huntington's Disease. |
| Q42481102 | Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways. |
| Q89963713 | Cortical and Striatal Circuits in Huntington's Disease |
| Q38035863 | Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes |
| Q38362877 | Corticostriatal synaptic adaptations in Huntington's disease |
| Q90117097 | Deficit in Motor Skill Consolidation-Dependent Synaptic Plasticity at Motor Cortex to Dorsolateral Striatum Synapses in a Mouse Model of Huntington's Disease |
| Q35181056 | Differential Synaptic and Extrasynaptic Glutamate-Receptor Alterations in Striatal Medium-Sized Spiny Neurons of Aged YAC128 Huntington's Disease Mice |
| Q48340405 | Differential cortical activation of the striatal direct and indirect pathway cells: reconciling the anatomical and optogenetic results by using a computational method |
| Q40102175 | Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease |
| Q34341619 | Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease |
| Q38234309 | Direct and indirect pathways of basal ganglia: a critical reappraisal |
| Q35782283 | Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease |
| Q52690256 | Disrupted striatal neuron inputs and outputs in Huntington's disease. |
| Q40989589 | Dopamine Induces Oscillatory Activities in Human Midbrain Neurons with Parkin Mutations |
| Q38121068 | Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility |
| Q39041217 | Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation |
| Q47570978 | Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model |
| Q35055109 | Functional Changes in Neocortical Activity in Huntington's Disease Model Mice: An in vivo Intracellular Study |
| Q27015687 | Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease |
| Q52685690 | HttQ111/+ Huntington's Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction. |
| Q46110034 | Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice |
| Q29144918 | Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease |
| Q35311070 | Impaired alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking and function by mutant huntingtin. |
| Q35116551 | In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease |
| Q36276521 | Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease |
| Q36338317 | Interplay between periodic stimulation and GABAergic inhibition in striatal network oscillations |
| Q37255018 | Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice |
| Q96228741 | Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease |
| Q26830654 | Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases |
| Q36940345 | Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models |
| Q64092417 | Mutant huntingtin enhances activation of dendritic Kv4 K channels in striatal spiny projection neurons |
| Q57471121 | Mutant huntingtin reduction in astrocytes slows disease progression in the bachd conditional huntington's disease mouse model |
| Q35747131 | Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease |
| Q35645271 | Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease |
| Q40938080 | Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model |
| Q36825003 | Neurobiology of rodent self-grooming and its value for translational neuroscience |
| Q90359231 | Neurodegenerative diseases: model organisms, pathology and autophagy |
| Q37275079 | Opioid self-administration results in cell-type specific adaptations of striatal medium spiny neurons |
| Q26749238 | Optogenetics for neurodegenerative diseases |
| Q90439419 | Overview of Huntington's Disease Models: Neuropathological, Molecular, and Behavioral Differences |
| Q37212391 | Partial Amelioration of Peripheral and Central Symptoms of Huntington's Disease via Modulation of Lipid Metabolism |
| Q37930190 | Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. |
| Q27011417 | Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease |
| Q52685691 | Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease. |
| Q36553261 | Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington disease |
| Q99551171 | Rate of torque development and striatal shape in individuals with prodromal Huntington's disease |
| Q41816120 | Regional and cell-type-specific effects of DAMGO on striatal D1 and D2 dopamine receptor-expressing medium-sized spiny neurons |
| Q28394979 | Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition |
| Q36931043 | Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington's disease |
| Q38568655 | Striatal synaptosomes from Hdh140Q/140Q knock-in mice have altered protein levels, novel sites of methionine oxidation, and excess glutamate release after stimulation |
| Q40507416 | Sustained mobilization of endogenous neural progenitors delays disease progression in a transgenic model of Huntington's disease |
| Q55437037 | Synaptopathy, circuitopathy and the computational biology of Huntington's disease. |
| Q28728849 | Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation |
| Q38223504 | The role of dopamine in Huntington's disease |
| Q50420577 | Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings. |
| Q58090420 | Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders |
| Q36740885 | Untangling Cortico-Striatal Connectivity and Cross-Frequency Coupling in L-DOPA-Induced Dyskinesia |
Search more.